Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


2 Acta Haematol
1 Am J Hematol
1 Eur J Haematol
1 Exp Hematol
1 Int J Hematol
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Pediatr Hematol Oncol
1 J Virol
4 Leuk Lymphoma
1 Leuk Res
1 Oncogene
1 Oncol Rep
1 PLoS Genet
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Haematol

  1. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Text format     Abstract available

  2. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Text format     Abstract available

    Am J Hematol

  3. GRIFFIN PT, Komrokji RS, Sweet K, Al Ali NH, et al
    Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
    Am J Hematol. 2017;92:232-237.
    PubMed     Text format     Abstract available

    Eur J Haematol

  4. GEELEN IGP, Thielen N, Janssen JJWM, Levin MD, et al
    Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survival.
    Eur J Haematol. 2017 Jul 18. doi: 10.1111/ejh.12928.
    PubMed     Text format     Abstract available

    Exp Hematol

  5. LAING AA, Harrison CJ, Gibson BES, Keeshan K, et al
    Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Exp Hematol. 2017 Jun 28. pii: S0301-472X(17)30237.
    PubMed     Text format     Abstract available

    Int J Hematol

  6. DI IANNI M, Olioso P, Giancola R, Santarone S, et al
    Treg-protected donor lymphocyte infusions: a new tool to address the graft-versus-leukemia effect in the absence of graft-versus-host disease in patients relapsed after HSCT.
    Int J Hematol. 2017 Jul 18. doi: 10.1007/s12185-017-2292.
    PubMed     Text format     Abstract available

    J Clin Oncol

  7. TURTLE CJ, Hay KA, Hanafi LA, Li D, et al
    Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.
    J Clin Oncol. 2017 Jul 17:JCO2017728519. doi: 10.1200/JCO.2017.72.8519.
    PubMed     Text format     Abstract available

    J Natl Cancer Inst

  8. GEBLER C, Lohoff T, Paszkowski-Rogacz M, Mircetic J, et al
    Inactivation of Cancer Mutations Utilizing CRISPR/Cas9.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available

    J Pediatr Hematol Oncol

  9. GERVASINI G, de Murillo SG, Jimenez M, de la Maya MD, et al
    Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.
    J Pediatr Hematol Oncol. 2017 Jul 17. doi: 10.1097/MPH.0000000000000908.
    PubMed     Text format     Abstract available

    J Virol

  10. ISHIHARA Y, Tanaka Y, Kobayashi S, Kawamura K, et al
    A unique T cell receptor amino acid sequence selected by HTLV-I Tax301-309-specific cytotoxic T-cells in HLA-A24:02+ asymptomatic carriers and adult T-cell leukemia/lymphoma patients.
    J Virol. 2017 Jul 19. pii: JVI.00974-17. doi: 10.1128/JVI.00974.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  11. ALLAN JN, Roboz GJ, Askin G, Ritchie E, et al
    CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.
    Leuk Lymphoma. 2017 Jul 18:1-8. doi: 10.1080/10428194.2017.1352089.
    PubMed     Text format     Abstract available

  12. SHORT NJ, Kantarjian H, Ravandi F, Huang X, et al
    A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.
    Leuk Lymphoma. 2017 Jul 18:1-8. doi: 10.1080/10428194.2017.1349907.
    PubMed     Text format     Abstract available

  13. RAUSCH CR, Marini BL, Benitez LL, Elias A, et al
    PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia dagger.
    Leuk Lymphoma. 2017 Jul 18:1-8. doi: 10.1080/10428194.2017.1349902.
    PubMed     Text format     Abstract available

  14. AMMANN EM, Shanafelt TD, Wright KB, McDowell BD, et al
    Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length.
    Leuk Lymphoma. 2017 Jul 18:1-7. doi: 10.1080/10428194.2017.1349905.
    PubMed     Text format     Abstract available

    Leuk Res

  15. MEDINGER M, Heim D, Gerull S, Halter J, et al
    Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Leuk Res. 2016;47:22-25.
    PubMed     Text format     Abstract available


  16. WU TS, Tan CT, Chang CC, Lin BR, et al
    B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

    Oncol Rep

  17. HUANG JL, Liu W, Tian LH, Chai TT, et al
    Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia.
    Oncol Rep. 2017 Jul 10. doi: 10.3892/or.2017.5802.
    PubMed     Text format     Abstract available

    PLoS Genet

  18. PATCHETT S, Musalgaonkar S, Malyutin AG, Johnson AW, et al
    The T-cell leukemia related rpl10-R98S mutant traps the 60S export adapter Nmd3 in the ribosomal P site in yeast.
    PLoS Genet. 2017;13:e1006894.
    PubMed     Text format     Abstract available

    PLoS One

  19. BANDYOPADHYAY S, Li J, Traer E, Tyner JW, et al
    Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia.
    PLoS One. 2017;12:e0179558.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.